A Year In Review
The RNA therapeutic landscape experienced transformative growth in 2024, driven by expanding applications in oncology, cardiovascular diseases, and immune-mediated disorders. With over 1,000 new drugs introduced and major advancements in siRNA, mRNA, and gene-editing modalities, RNA therapies are reshaping the future of precision medicine. Regulatory approvals and a wave of clinical trials showcase RNA’s potential beyond vaccines, further cementing its role in therapeutic innovation.
Download Now
Stay informed and stay competitive. The Beacon RNA 2024 Landscape Review is your comprehensive guide to RNA therapeutics, providing exclusive insights on clinical growth, emerging disease targets, and strategic investments. Whether you’re scouting partnerships or aligning with regulatory trends, this report equips you with data-driven intelligence to confidently lead your next development strategy. Download now and gain an edge in tomorrow’s RNA-driven breakthroughs.
Part 1: The RNA Drug Development Landscape
Part 2: The Trial & Commercial Landscapes
Part 3: Insights and Trends from Hanson Wade Intelligence
Report Contents
The Drug Landscape
Explore the latest growth trends across RNA modalities, with over 4,800 drugs spanning mRNA, siRNA, and beyond.
The Trial Landscape
Track RNA’s clinical momentum with 2,200+ ongoing trials and detailed insights into newly initiated programs.
The Commercial Market
Dive into strategic deal-making, with $70 billion in transactions reshaping RNA investments and partnerships.
A Future Look at RNA
Understand what’s next for RNA as targeting approaches redefine precision delivery.
Regulatory Announcements
Review pivotal 2024 approvals, IND submissions, and regulatory designations that are propelling RNA therapies forward.
You May Also Be Interested In...
RNA: 2024 Landscape Review
Cell Therapy: 2024 Landscape Review
Gene Therapy: 2024 Landscape Review
H1 2024 Immune Tolerance Landscape Review
H1 2024 RNA Landscape Review
H1 2024 Gene Therapy Landscape Review
Find Out More
Beacon is the ultimate decision-support tool for developers of complex therapeutics. By combining market-defining proprietary ontologies with the most accurate and comprehensive life sciences data, we offer our customers unmatched visibility into the drug, trial, and commercial landscapes. Each dataset is enriched with proprietary, hyper-targeted search and filtering capabilities tailored to specific modalities, in-depth data, and expert-curated market insights. With Beacon’s robust database solution, you can confidently navigate critical decisions and drive success.
With Beacon, you can make drug development decisions with confidence. This is why 23 out of the world’s top 25 drug developers trust us.
Any questions? Get in touch
Our dedicated account and research teams can help you with questions by showing you how this insight and data is collated on Beacon.
